DE69415675D1 - Verfahren zur Ausfällung von natürlichen Avermectinen, sowie Fermentationsverfahren zur Herstellung derselben - Google Patents

Verfahren zur Ausfällung von natürlichen Avermectinen, sowie Fermentationsverfahren zur Herstellung derselben

Info

Publication number
DE69415675D1
DE69415675D1 DE69415675T DE69415675T DE69415675D1 DE 69415675 D1 DE69415675 D1 DE 69415675D1 DE 69415675 T DE69415675 T DE 69415675T DE 69415675 T DE69415675 T DE 69415675T DE 69415675 D1 DE69415675 D1 DE 69415675D1
Authority
DE
Germany
Prior art keywords
natural
pct
precipitation
avermectins
sec
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69415675T
Other languages
English (en)
Other versions
DE69415675T2 (de
Inventor
Abdullah R Ali
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pfizer Inc
Original Assignee
Pfizer Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Inc filed Critical Pfizer Inc
Publication of DE69415675D1 publication Critical patent/DE69415675D1/de
Application granted granted Critical
Publication of DE69415675T2 publication Critical patent/DE69415675T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20Bacteria; Culture media therefor
    • C12N1/205Bacterial isolates
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P19/00Preparation of compounds containing saccharide radicals
    • C12P19/44Preparation of O-glycosides, e.g. glucosides
    • C12P19/60Preparation of O-glycosides, e.g. glucosides having an oxygen of the saccharide radical directly bound to a non-saccharide heterocyclic ring or a condensed ring system containing a non-saccharide heterocyclic ring, e.g. coumermycin, novobiocin
    • C12P19/62Preparation of O-glycosides, e.g. glucosides having an oxygen of the saccharide radical directly bound to a non-saccharide heterocyclic ring or a condensed ring system containing a non-saccharide heterocyclic ring, e.g. coumermycin, novobiocin the hetero ring having eight or more ring members and only oxygen as ring hetero atoms, e.g. erythromycin, spiramycin, nystatin
    • C12P19/623Avermectin; Milbemycin; Ivermectin; C-076
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12RINDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00Microorganisms ; Processes using microorganisms
    • C12R2001/01Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • C12R2001/465Streptomyces
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00Chemistry: molecular biology and microbiology
    • Y10S435/8215Microorganisms
    • Y10S435/822Microorganisms using bacteria or actinomycetales
    • Y10S435/886Streptomyces

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Health & Medical Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Biomedical Technology (AREA)
  • Virology (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Saccharide Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Compounds Of Unknown Constitution (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DE69415675T 1993-07-23 1994-04-26 Verfahren zur Ausfällung von natürlichen Avermectinen, sowie Fermentationsverfahren zur Herstellung derselben Expired - Fee Related DE69415675T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US9674593A 1993-07-23 1993-07-23
PCT/IB1994/000080 WO1995003419A1 (en) 1993-07-23 1994-04-26 Method for precipitating natural avermectins

Publications (2)

Publication Number Publication Date
DE69415675D1 true DE69415675D1 (de) 1999-02-11
DE69415675T2 DE69415675T2 (de) 1999-05-20

Family

ID=22258886

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69415675T Expired - Fee Related DE69415675T2 (de) 1993-07-23 1994-04-26 Verfahren zur Ausfällung von natürlichen Avermectinen, sowie Fermentationsverfahren zur Herstellung derselben

Country Status (16)

Country Link
US (2) US5686274A (de)
EP (1) EP0710290B1 (de)
JP (1) JP2828343B2 (de)
AT (1) ATE175240T1 (de)
AU (1) AU674743B2 (de)
BR (1) BR9407141A (de)
CA (1) CA2167186C (de)
CO (1) CO4230201A1 (de)
DE (1) DE69415675T2 (de)
DK (1) DK0710290T3 (de)
ES (1) ES2125446T3 (de)
FI (2) FI112092B (de)
GR (1) GR3029285T3 (de)
NZ (1) NZ263615A (de)
WO (1) WO1995003419A1 (de)
ZA (1) ZA945415B (de)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1998056939A1 (fr) * 1997-06-09 1998-12-17 Vladimir Alexandrovich Mosin Souche de streptomyces avermitilis, procede de separation de complexes d'avermectine et preparations destinees a la protection d'animaux et de vegetaux
KR100419554B1 (ko) * 1999-10-29 2004-02-19 주식회사유한양행 아버멕틴의 정제방법
US6872708B2 (en) * 2001-09-10 2005-03-29 Mitsukazu Matsumoto Local injection prescription
JP4373080B2 (ja) * 2002-12-24 2009-11-25 三井化学アグロ株式会社 ミルベマイシン類の精製法
CN101084300B (zh) * 2004-12-23 2010-09-22 Jp实验室有限公司 制备洗涤剂的方法
CN103333214B (zh) * 2013-07-03 2015-08-12 大庆志飞生物化工有限公司 一种阿维菌素B2a精粉的制备方法

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FI56187C (fi) * 1970-07-02 1979-12-10 Takeda Chemical Industries Ltd Foerfarande foer framstaellning av antibiotiskt aktiva estrar av makrolidglykosiderna b-5050 eller tetrahydro b-5050
US4017516A (en) * 1972-11-15 1977-04-12 Schering Corporation Novel monoesters of rosamicin
SE434277B (sv) * 1976-04-19 1984-07-16 Merck & Co Inc Sett att framstella nya antihelmintiskt verkande foreningar genom odling av streptomyces avermitilis
US4201861A (en) * 1977-10-03 1980-05-06 Merck & Co., Inc. Acyl derivatives of C-076 compounds
US4307085A (en) * 1979-11-09 1981-12-22 Schering Corporation Antibiotic AR-5 complex, antibiotics coproduced therewith and derivatives thereof
US4389397A (en) * 1980-08-04 1983-06-21 Merck & Co., Inc. Solubilization of ivermectin in water
US4399274A (en) * 1981-07-02 1983-08-16 Merck & Co., Inc. Isolation of non-ionic lipophilic materials on macroreticular polymeric absorbents
US4703009A (en) * 1983-03-08 1987-10-27 Merck & Co., Inc. RDNA cloning vector pVE1, deletion and hybrid mutants and recombinant derivatives thereof products and processes
ES8800986A1 (es) * 1985-07-27 1987-12-01 Pfizer Un procedimiento para la produccion de un nuevo derivado de avermectina
US5077348A (en) * 1986-10-31 1991-12-31 Toyo Ink Manufacturing Co., Ltd. Aqueous coating composition, process for the production thereof and aqueous coating
US5077398A (en) * 1986-11-18 1991-12-31 Merck & Co., Inc. Process for isolation of avermectin B1 components with improved purity and subsequent isolaton of B2 components
US5234831A (en) * 1987-01-23 1993-08-10 Pfizer Inc Cultures for production of B avermectins
JP2888586B2 (ja) * 1990-03-05 1999-05-10 社団法人北里研究所 エバーメクチンの特定成分を選択生産するための微生物およびその選択的製造法

Also Published As

Publication number Publication date
GR3029285T3 (en) 1999-05-28
BR9407141A (pt) 1996-09-17
US5686274A (en) 1997-11-11
CA2167186A1 (en) 1995-02-02
CA2167186C (en) 1999-01-26
CO4230201A1 (es) 1995-10-19
DE69415675T2 (de) 1999-05-20
DK0710290T3 (da) 1999-08-30
FI960304A (fi) 1996-01-22
FI20030488A (fi) 2003-04-01
FI112375B (fi) 2003-11-28
FI112092B (fi) 2003-10-31
JP2828343B2 (ja) 1998-11-25
EP0710290A1 (de) 1996-05-08
ATE175240T1 (de) 1999-01-15
WO1995003419A1 (en) 1995-02-02
ZA945415B (en) 1996-01-22
US5905034A (en) 1999-05-18
NZ263615A (en) 1997-08-22
FI960304A0 (fi) 1996-01-22
AU674743B2 (en) 1997-01-09
ES2125446T3 (es) 1999-03-01
AU6436194A (en) 1995-02-20
JPH08506966A (ja) 1996-07-30
EP0710290B1 (de) 1998-12-30

Similar Documents

Publication Publication Date Title
DE59309101D1 (de) Verfahren zur in vivo gewinnung von inhaltsstoffen aus zellen
DE69631996D1 (de) Verfahren zur Herstellung von acylierten Proteinpuder
ATE106083T1 (de) Verfahren zur herstellung von rhamnose aus rhamnolipiden.
ATE126223T1 (de) Verfahren zur herstellung von ascorbinsäure.
DK0475451T3 (da) Fremgangsmåde til fremstilling af cholesterolreduceret æggeblomme
EP0399573A3 (de) Verfahren zur Wiedergewinnung von Aminosäuren aus wässerigen Mischungen
ATE360637T1 (de) Verfahren zur herstellung von polyphenolischen adhäsionsproteinen
ATE340639T1 (de) Verfahren zur herstellung von teilchen
ATE464390T1 (de) Verfahren zur herstellung von insulinverbindungen
ATE169610T1 (de) Rückgewinnung von kohlensäure aus einer amin- und extraktionsverstärker enthaltenden wässrigen lösung
ATE175240T1 (de) Verfahren zur ausfällung von natürlichen avermectinen, sowie fermentationsverfahren zur herstellung derselben
DE69403210T3 (de) Verfahren zur herstellung von n-acetylneuraminsäure
DE69413974D1 (de) Verfahren zur herstellung von n-acetyl-neuraminsäurederivaten
DE69841553D1 (de) Verfahren zur herstellung von entölten phosphtiden
DE69229677T2 (de) Verfahen zur herstellung von (s)(+)-4, 4'-(1-methyl-1,2-ethandiyl)-bis(2,6-piperazindion
DE58908961D1 (de) Verfahren zur Isolierung von 2-Keto-polyhydroxy-C6-carbonsäuren, insbesondere von 2-Keto-L-gulonsäure aus wässrigen Fermentationsausträgen.
ATE41919T1 (de) Verfahren zur herstellung von gegebenenfalls in 5-stellung halogenisierten 6-(nieder)-alkoxy-1naphthoes|urenund den entsprechenden estern.
ATE282616T1 (de) Verfahren zur herstellung von wasserfreien mirtazapin-kristallen.
GB1453063A (en) Method for purifying 3,5-cyclic-adenylic acid or 3,5-cyclic- deoxy-adenylic acid
ATE198198T1 (de) Verfahren zur gewinnung von procyanidolischen oligomeren
RU95100864A (ru) Способ выделения рибофлавина из культуральной жидкости
ATE130844T1 (de) Verfahren zur extraktion eines aminosäureesters.
KR960021047A (ko) 사상자로부터 혈액응고 작용이 있는 분획의 제조방법
MY109343A (en) Process for extracting protein curculin
KR850006878A (ko) 동물기시부(animal origin)의 펩티드(peptide)와 아미노산 용액을 효소처리에 의해 얻는 방법

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee